2-230168917-AT-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_080424.4(SP110):c.*206delA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.022 ( 70 hom., cov: 0)
Exomes 𝑓: 0.085 ( 67 hom. )
Consequence
SP110
NM_080424.4 3_prime_UTR
NM_080424.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.76
Publications
0 publications found
Genes affected
SP110 (HGNC:5401): (SP110 nuclear body protein) The nuclear body is a multiprotein complex that may have a role in the regulation of gene transcription. This gene is a member of the SP100/SP140 family of nuclear body proteins and encodes a leukocyte-specific nuclear body component. The protein can function as an activator of gene transcription and may serve as a nuclear hormone receptor coactivator. In addition, it has been suggested that the protein may play a role in ribosome biogenesis and in the induction of myeloid cell differentiation. Alternative splicing has been observed for this gene and three transcript variants, encoding distinct isoforms, have been identified. [provided by RefSeq, Jul 2008]
SP110 Gene-Disease associations (from GenCC):
- hepatic veno-occlusive disease-immunodeficiency syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0633 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0222 AC: 3284AN: 147992Hom.: 70 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
3284
AN:
147992
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0845 AC: 23152AN: 273982Hom.: 67 Cov.: 0 AF XY: 0.0875 AC XY: 12776AN XY: 146034 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
23152
AN:
273982
Hom.:
Cov.:
0
AF XY:
AC XY:
12776
AN XY:
146034
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
624
AN:
8580
American (AMR)
AF:
AC:
1191
AN:
12828
Ashkenazi Jewish (ASJ)
AF:
AC:
543
AN:
8204
East Asian (EAS)
AF:
AC:
2399
AN:
19926
South Asian (SAS)
AF:
AC:
4225
AN:
34332
European-Finnish (FIN)
AF:
AC:
1142
AN:
14650
Middle Eastern (MID)
AF:
AC:
104
AN:
1138
European-Non Finnish (NFE)
AF:
AC:
11700
AN:
158892
Other (OTH)
AF:
AC:
1224
AN:
15432
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.370
Heterozygous variant carriers
0
1200
2399
3599
4798
5998
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0222 AC: 3284AN: 148062Hom.: 70 Cov.: 0 AF XY: 0.0220 AC XY: 1584AN XY: 72000 show subpopulations
GnomAD4 genome
AF:
AC:
3284
AN:
148062
Hom.:
Cov.:
0
AF XY:
AC XY:
1584
AN XY:
72000
show subpopulations
African (AFR)
AF:
AC:
256
AN:
40340
American (AMR)
AF:
AC:
148
AN:
14880
Ashkenazi Jewish (ASJ)
AF:
AC:
67
AN:
3434
East Asian (EAS)
AF:
AC:
21
AN:
5066
South Asian (SAS)
AF:
AC:
327
AN:
4708
European-Finnish (FIN)
AF:
AC:
239
AN:
9426
Middle Eastern (MID)
AF:
AC:
13
AN:
282
European-Non Finnish (NFE)
AF:
AC:
2177
AN:
66978
Other (OTH)
AF:
AC:
35
AN:
2050
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
138
276
415
553
691
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Hepatic veno-occlusive disease-immunodeficiency syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.